|

XP-DC vaccinations Clinical Trials

1 actively recruiting trial

Also known as: cdc1, dendritic cell vaccine

Pipeline

Phase 1/2: 1

Top Sponsors

  • Radboud University Medical Center1

Indications

  • Ovarian Carcinoma1
  • Epithelial Ovarian Cancer1
  • Cancer1

Other1 trial

NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.